ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals Inc (QB) (ELTP)

0.1925
0.00
(0.00%)
Closed July 26 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.1925
Bid
0.184
Ask
0.1948
Volume
387,558
0.19 Day's Range 0.1949
0.037 52 Week Range 0.2119
Market Cap
Previous Close
0.1925
Open
0.1937
Last Trade Time
Financial Volume
$ 74,546
VWAP
0.192347
Average Volume (3m)
653,965
Shares Outstanding
1,068,273,108
Dividend Yield
-
PE Ratio
10.11
Earnings Per Share (EPS)
0.02
Revenue
56.63M
Net Profit
20.11M

About Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma... Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Carson City, Nevada, USA
Founded
1970
Elite Pharmaceuticals Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ELTP. The last closing price for Elite Pharmaceuticals (QB) was $0.19. Over the last year, Elite Pharmaceuticals (QB) shares have traded in a share price range of $ 0.037 to $ 0.2119.

Elite Pharmaceuticals (QB) currently has 1,068,273,108 shares outstanding. The market capitalization of Elite Pharmaceuticals (QB) is $205.64 million. Elite Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of 10.11.

ELTP Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0001-0.05192107995850.19260.20.194412290.19369363CS
4-0.0074-3.701850925460.19990.210.1657610300.18990328CS
120.0629548.5912774990.129550.210.12346539650.17365158CS
260.00050.2604166666670.1920.210.12138237110.16682892CS
520.153865398.2528795130.0386350.21190.03711619010.13696515CS
1560.14252850.050.21190.0237262080.09102831CS
2600.14175279.3103448280.050750.21190.0238265170.08218696CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CGTXCognition Therapeutics Inc
$ 3.44
(45.15%)
4.65M
NAMSNewAmsterdam Pharma Company NV
$ 22.49
(19.25%)
18.82k
RNAZTransCode Therapeutics Inc
$ 0.3474
(17.52%)
6.63M
YYGHYY Group Holding Ltd
$ 0.84
(14.60%)
743
YIBOPlanet Image International Ltd
$ 3.32
(13.89%)
56.87k
VTVTvTv Therapeutics Inc
$ 13.0022
(-38.67%)
33.34k
CEROCERo Therapeutics Holdings Inc
$ 0.1661
(-35.12%)
3.54M
TGLTreasure Global Inc
$ 1.40
(-24.32%)
54.54k
LUXHLuxUrban Hotels Inc
$ 0.1587
(-16.91%)
1.31M
JCSEJE Cleantech Holdings Limited
$ 1.1001
(-12.69%)
681
SLNASelina Hospitality PLC
$ 0.0276
(-8.00%)
24.54M
RNAZTransCode Therapeutics Inc
$ 0.3474
(17.52%)
6.63M
CGTXCognition Therapeutics Inc
$ 3.44
(45.15%)
4.65M
TLTiShares 20 plus Year Treasury Bond
$ 92.90
(-0.10%)
3.91M
CEROCERo Therapeutics Holdings Inc
$ 0.1661
(-35.12%)
3.54M

ELTP Discussion

View Posts
jammy32 jammy32 57 minutes ago
Why isn’t the stock price reflecting all of this good.
🤮 1 🦨 1
CMDawg CMDawg 2 hours ago
I don’t bet my life savings on a stock. I bet what I can lose if things go wrong, I will be fine. GLtU
👍️ 1
jammy32 jammy32 3 hours ago
If true, why doesn’t someone step up and buy them now
💩 1 🗑️ 1 🤡 2
Pharma Sleuth Pharma Sleuth 3 hours ago
I've been telling people for a long time that it's the best investment I've seen. Outside of an act of God, hurricane or something they are just going to keep making more drugs. It's really not complicated.

Where's their overhang? Cash flow a little but now they have 20m working capital. Account receivables catching up.

Debt is basically their mortgage and the low rate NJ stuff which is like a couple million they pay on.

Most of these companies are servicing a ton of debt. Which means your margins are lower which means you can't be as competitive.
👍️ 1 💥 1
Pharma Sleuth Pharma Sleuth 3 hours ago
Probably more frustrating trying to remember all the passwords to all your IDs.
👍️ 1 💯 1
Pharma Sleuth Pharma Sleuth 3 hours ago
It's been manipulated for a long time. As you can see by the overseas hired hands that work this board, someone needs the stock cheap. You can debate the why, but you can't debate the company.

PE has been looking backwards. But we reached critical mass. Now it's just printing money. Not saying manufacturing drugs is easy. It's obviously complex. But if you can do it, the way Elite can and have the manufacturing space (just doubled) you can basically pick what you want to make the most money on.
👍️ 1 💯 1
Pharma Sleuth Pharma Sleuth 3 hours ago
Basically an interest free loan. Paid back with reverse interest. It's funny how this is still OTC. And may be when it's sold. That's another debate. But all the drugs are in your local pharmacy and you know the names of most of them. Even just an average person knows them. Billion dollar drugs. Crazy the story being told here.
👍️ 1
jammy32 jammy32 3 hours ago
I agree that Nasrat has done a good job. Just frustrated with the past 12 of the 13 years.
👛 1 💋 1
Pharma Sleuth Pharma Sleuth 3 hours ago
I don't know how to read Prasco. It's great revenue. My question is always on how they figure out quota. Prasco has a large reach
👍️ 1
Pharma Sleuth Pharma Sleuth 3 hours ago
That's a big one. $5 billion dollar drug pending approval. Also in shortage I believe. Lol
👍️ 1 💯 1
jammy32 jammy32 3 hours ago
Question for the board - what was Nasrat talking about when he was guessing on annual revenue. What was he so embarrassed about ? What was he talking about with Carter. Just seemed odd
👗 1 👠 1 🗑️ 1 🤡 1
jammy32 jammy32 4 hours ago
I don’t think I’ll be too worried about that. My post are not insulting anyone. There’s no profanity. They’re just my opinion about elite. Again, opinion which I am entitled to do. This is a board to discuss stocks after all. No one should ever buy or sell based on anything that is said on this or any other message board. Especially nothing that I ever say as again, just sharing my opinion.
💩 1 🤮 1 🥸 1
CMDawg CMDawg 5 hours ago
Fine with that. I got millions of shares so either way I win. I cannot lose!
👍️ 1
Dr Speculator Ninja Dr Speculator Ninja 5 hours ago
Sure, unless you are sent back to IHub jail for violating site rules, terms and conditions. Can't 'post as needed' from there. 🤔🤣🛑 Next time is likely a permanent ban.
👍️ 1 💯 1
imanjen13 imanjen13 5 hours ago
I say we hit .253 before we hit the143. Loser buys the first bottle of Dom Perignom at the party you hold in your suite in Vegas.
👍️ 1 💯 1
CMDawg CMDawg 5 hours ago
Still not convinced. They said the .123 gap was not going to be hit and guess what…. It hit it…even with the .17 support at the time.
👍️0
Pharma Sleuth Pharma Sleuth 5 hours ago
I have as at right about $1.10.

But I am ommitting the unknown unknowns. Meaning over this time, what other drugs are in development and will be trialed and submitted.

I am basing this on what I know today

Nasrat is like a duck. Really calm on the surface but the feet are moving fast underneath. No hype. No fluff. Just growing the business. Revenue parabolic YOY.
👍️ 4 👑 1 💯 2
Lazarus Elite Lazarus Elite 5 hours ago
Minimum buyout price of $ELTP should be $1.65. MINIMUM.
👍️ 1 💯 1 💲 1
Lazarus Elite Lazarus Elite 5 hours ago
Vyvanse approval imminent - another $5 billion dollar drug for ELTP to sell.
👍️ 1 💥 1
Lazarus Elite Lazarus Elite 5 hours ago
Nasrat is an attorney and has shown hesitation to fight in the opioid space. If he feels confident fighting Purdue at this time, he must have an excellent reason. All logic supports this.
👍️ 1 💯 2
Lazarus Elite Lazarus Elite 5 hours ago
Estimates for Prasco revenue? I say at least another $12 million per year. Have to add that to valuation.
👍️ 2 💯 1
Lazarus Elite Lazarus Elite 5 hours ago
We should do 10% market penetration of the new drugs. That should be another $100 million in revenue this year.
👍️ 1 💯 1
Lazarus Elite Lazarus Elite 5 hours ago
Nasrat is the greatest CEO!! Just acquired a billion dollar drug pipeline for $900k minus inflation - true cost was about $600k.
👍️ 1 💯 1
Lazarus Elite Lazarus Elite 5 hours ago
Huge revenue growth incoming. This stock is going to pop!!!
👍️ 1 💯 1
Lazarus Elite Lazarus Elite 5 hours ago
PE ratio is too low for a company with this much upside!!
👍️ 1 💯 1
Lazarus Elite Lazarus Elite 5 hours ago
Man this is the best stock on the OTC!!!
👍️ 1 💯 1
Lazarus Elite Lazarus Elite 5 hours ago
In honor of all the paid bashers, let's give a big shout out to Nasrat. Incredible CEO able to deliver excellent returns for long shareholders.
👍️ 1 💯 1
imanjen13 imanjen13 6 hours ago
In July 2016 there was a GAP at .25. I think it is more likely that gap will be filled before your fall into the GAP .143 prediction. Check it out.
Regarding technical analysis, the stock has held above .19 since July 18 so that appears to be the current support level.
👍️ 1 💯 1
CMDawg CMDawg 6 hours ago
I am saying most GAPS get touched unless a game changing news happens. I buy all the time above the GAPs but I leave a lot of $$$ ready just in case it hits it. The GAP stands at .143. All ELTP gaps have been hit since the company was founded!!
👍️ 1
Pharma Sleuth Pharma Sleuth 6 hours ago
Why aren't you allowed to say what drugs are pending launch now and if the market value of the drugs is over a billion dollars.

A) you don't know

B) you aren't allowed to say

C) both A and B
👍️ 2 😂 2
Pharma Sleuth Pharma Sleuth 6 hours ago
Why are you working so hard today? Do you even know?
👍️ 2 😂 2
jammy32 jammy32 6 hours ago
I do appreciate your posts by the way. They seem to add value. Thanks
👍️ 1 🚽 1 🧻 1
jammy32 jammy32 7 hours ago
Let’s be honest

Has Nasrat been ceo for 13 years. Yes

Has the stock gone up some - yes

Did Nasrat follow Diane’s advice, a secretary, and utilize LPC to get the float to over a billion sharwes. Yes

Did Nasrat nasdaq soon in 2017 and numerous times after that - yes

Are we on the Nasdaq - no

Did Nasrat say he was unwinding MIkAh - yes but can’t validate

Did he unwind MIKAH - no

Did Nasrat say dollarland - yes

Are we at a dollar - hell no.

Read the transcripts I did
💩 1 🗑️ 1 🤡 1 🤮 1
jammy32 jammy32 7 hours ago
No thanks. I will continue to post as needed. Thanks
💩 1 🗑️ 1 🤡 2 🤮 1
jammy32 jammy32 7 hours ago
Some people that obviously lost money here and are very touchy. I post about business and that’s all. Nothing personal. No gap BS. No I’m loading up with more BS. No nonsense. Feel free to reply but don’t cry about spilled milk. You lost money. So be it.
🗑️ 2 🤡 2
BZ2 BZ2 7 hours ago
What do you mean “Our Shares” I thought you sold at $0.15. Why are you here. Keep your word and just leave.
👍️ 3 💯 2
Pharma Sleuth Pharma Sleuth 7 hours ago
Damn, how long did it take to remember this password to this fake ID. 13 years. Jerry says get a better job.
👍️ 2 💯 2
NASDAQ2020 NASDAQ2020 7 hours ago
Shortages: Elites future looks bright
Perfect storm is a brewing

FDA shortage link for Adderall:
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet&st=c&tab=tabs-1

FDA shortage link for Vyvance
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c

FDA shortage link for Concerta
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release&st=c

FDA shortage link for Naltrexone
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c

FDA shortage link for Methotrexate
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methotrexate%20Sodium%20Tablet&st=c
Bullish
BULLISH
💥 1 🔥 1 🚀 2
Pharma Sleuth Pharma Sleuth 7 hours ago
It's funny. They literally aren't allowed to say. I do believe they probably may not know. Ask them anything about what the company is doing and they aren't allowed to answer. It's like some weird kryptonite. Like vampires and crosses.

Ask them the market value of the drugs. That's always fun too. Lol
👍️ 2 💯 2
NASDAQ2020 NASDAQ2020 7 hours ago
X. $0.0269
X. $0.03
X. $0.04
X. $0.05
X. $0.06
X. $0.07
X. $0.08
X. $0.09
X. $0.10
X. $0.11
X. $0.12
X. $0.13
X. $0.14
X. $0.15
X. $0.16
X. $0.17
X. $0.18
X. $0.19
_. $0.20
_. $0.21
👍️ 1 💥 1 🚀 1
Hello Newman Hello Newman 7 hours ago
US Antibiotics in Tennessee. Makes Amoxicillin
🤔 1 ❓️ 1
jammy32 jammy32 8 hours ago
Can’t open it. It’s not elite, is it
💩 1
jammy32 jammy32 8 hours ago
It’s always soon - like Nasrat said in 2017. Getting on the. Nasdaq soon.
🗑️ 2 🤡 2
Hello Newman Hello Newman 8 hours ago
I don't know if this link will open unless you are a subscriber to WSJ but the headline is noteworthy.

https://www.wsj.com/health/pharma/america-is-running-out-of-generic-drugmakers-another-one-is-on-the-brink-dbd8bb17?mod=djem10point
👍️0
jammy32 jammy32 8 hours ago
13 years later by the way. Why does no one acknowledge that
🗑️ 2 🤡 2
jammy32 jammy32 8 hours ago
LOL. How much is hundred invested in ELTP worth when Nsrat started vs QqQ.

Nasrat made money. Don’t get confused

Just my opinion
🗑️ 2 🤡 2
jammy32 jammy32 8 hours ago
It’s about making money. That’s all. All the non sense about Goats, Gap, it’s about to get real, dollarland, no one can stop us - means nothing. We needed him to have a great CC. To be a leader that showed that he can take us to the next level. I just don’t hear that. My opinion
💩 1 🦨 1
jammy32 jammy32 8 hours ago
I’m sorry but repeating the same is not new. It’s just the same old stuff. Nasrat needs to either do something big. Resign , get a new ceo or sell the company. I’d like our shares back as well
🗑️ 2 🤡 2
jammy32 jammy32 8 hours ago
It’s non sense.
🤮 1
Hello Newman Hello Newman 8 hours ago
CMDawg, you've been posting about filling that gap for so long. Sorry, but I don't understand why that gap has to fill before this stock can run. Can you explain your point of view on this? I'm not saying what you are posting is wrong, I just don't understand and would like to know why it's so important. TIA
👍️ 1